Select Country

Latest news

Bracco Diagnostics Inc. Receives First U.S. FDA Approval for Barium-Based Product Used for Contrast Radiography E-Z-HD™ (BARIUM SULFATE) FOR ORAL SUSPENSION Represents a Breakthrough for a Class of Products Used for More Than 100 Years

Press release


Bracco DIAGNOSTICS INC. and Amerinet announce GROUP PURCHASING agreement to INCLUDE LUMASON TM (sulfur hexafluoride lipid-type A microspheres) for injectable suspension for contrast echocardiography

Press release


Click here to learn about the TRUTH1 Study.
Reference 1. Maravilla KR, Smith MP, Vymazal J, Goyal M, Herman M, Baima JJ, Babbel R, Vaneckova M, Zižka J, Colosimo C, Urbańczyk-Zawadzka M, Mechl M, Bag AK, Bastianello S, Bueltmann E, Hirai T, Frattini T, Kirchin MA, Pirovano G. Are There Differences between Macrocyclic Gadolinium Contrast Agents for Brain Tumor Imaging? Results of a Multicenter Intraindividual Crossover Comparison of Gadobutrol with Gadoteridol (the TRUTH Study). AJNR Am J Neuroradiol. 2014 Oct 9. [Epub ahead of print]

Congress calendar

From February 21 to 23, 2016
Las Vegas, NV

Advanced Practices in Voice & Dysphagia

From February 24 to 27, 2016
Tucson, AZ


Educational Events


Established to compare various clinical approaches for targeted diagnostic imaging.

Read more


Designed to help physicians stay abreast of the latest changes and applications in magnetic resonance.

Read more